Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Netherlands,Portugal,Taiwan, Province of China,France,United Kingdom,Italy,Spain,Germany,Australia - Promoter: nct
nct
Update Il y a 5 ans
Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation
Primary Objective: - Evaluate the rate of Atrial Fibrillation (AF) recurrences one month after randomization according to different timings of initiation of dronedarone. Secondary Objective: - Evaluate the rate of AF recurrences two months after randomization. - Assess the safety of the change from amiodarone to dronedarone - Assess dronedarone safety - Explore dronedarone and its active metabolite plasma level (in a subset of countries) - Explore potential Pharmacokinetic (PK) interaction between dronedarone and amiodarone (in a subset of countries)
Country
Australia
,
Austria
,
Estonia
,
Finland
,
France
,
Germany
,
Israel
,
Italy
,
Korea, Republic of
,
Mexico
,
Netherlands
,
Portugal
,
Spain
,
Switzerland
,
Taiwan, Province of China
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease
This is a multicenter, randomized, double blind, parallel group study of 6 months' treatment with SLV308 as monotherapy in patients with early stage PD. An open label safety extension to this study is planned as a separate protocol for patients who are willing and eligible to participate.
Country
Australia
,
Czech Republic
,
Estonia
,
France
,
Germany
,
India
,
Italy
,
Lithuania
,
Malaysia
,
Netherlands
,
Poland
,
Portugal
,
South Africa
,
Spain
,
Taiwan, Province of China
,
Thailand
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).
Country
Australia
,
Austria
,
Belgium
,
Canada
,
China
,
Czech Republic
,
Denmark
,
Finland
,
France
,
Germany
,
Greece
,
Hungary
,
Israel
,
Italy
,
Latvia
,
Lithuania
,
Netherlands
,
New Zealand
,
Philippines
,
Poland
,
Portugal
,
Russian Federation
,
Singapore
,
South Africa
,
Spain
,
Switzerland
,
Taiwan, Province of China
,
Thailand
,
Turkey
,
Ukraine
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1